SCM
7.12.2023 19:52:29 CET | ACCESS Newswire | Press release
KYIV, UKRAINE / ACCESSWIRE / December 7, 2023 / Mariupol Reborn has been running for a year, planning the regeneration of Ukraine's famous seaside city. With support from across Ukraine and Europe, including from the SCM Group, it has developed a fast recovery plan and a long-term vision. And, importantly, it is providing vital support for the people of Mariupol.
Tens of thousands of Mariupol residents were killed in the six weeks after the full-scale invasion in February 2022 as a direct consequence of Russian aggression. Hundreds of thousands of Mariupol residents have been displaced.
Vadym Boychenko, the mayor of Mariupol, said: "People are our greatest assets. Lost lives are our greatest pain. Mariupol's struggle will go down in history as an example of extraordinary heroism. They deserve the best home to return to and our goal is to create that. We know the government of Ukraine and our military will return Mariupol to Ukrainians. And when that happens, we will be ready to start work on Day One."
The Fast Recovery Plan will get the city running, prioritizing housing and utilities. The Russians have destroyed 90% of the city's infrastructure, half the apartment buildings, 15 hospitals, 63 schools and 40,000 houses have been damaged.
Mariupol Reborn has also started developing the city's long-term regeneration plan, working with Europe's leading architects, urban planners and experts in desovietization. The four visions are here.
Olexander Vyshniakov, director of Mariupol Reborn and Head of community development at Metinvest Holding, said, "Socially responsible businesses have a clear duty to support the communities they work in. That's why Rinat Akhmetov's SCM Group is Mariupol's main partner. The Group's businesses are also doing everything they can across Ukraine, providing employment and paying taxes, to maintain stability now and provide the platform for post-war development. Mariupol Reborn is a key part of our contribution to Ukraine's reconstruction."
Mariupol Reborn has widespread support, including USAID's Economic Support for Ukraine project. The SCM Group has allocated $1.5 million to fund nine programmes. These include the development of the visions, and offices in Lviv, Dnipro and Warsaw, where the project is gathering expertise and securing international partnerships.
Cities across Europe have already offered support, including Utrecht, Vilnius and Gdansk. This is important because Mariupol has a lot to learn, particularly from those that suffered destruction in previous wars.
Mariupol Reborn is also providing housing for displaced Mariupol people now. With financial support from the French government, the project has developed dormitories in Dnipro.
Ukrainian businessman Rinat Akhmetov said, "The Russian invasion has destroyed the lives of hundreds of thousands of peaceful Mariupol residents. And it has ended the lives of far too many: one was too many. Therefore, it is crucially important we do not leave people alone with their misfortune. That's why we must provide the people of Mariupol with homes, however temporary."
Contact Information:
Hanna Korotych
The SCM Group
hanna.korotych@scm.com.ua
+380 (97) 347 70 39
Charlie Pryor
Leidar
charlie.pryor@leidar.com
+44 7958975667
SOURCE: The SCM Group
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
